Successful pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT) Meeting Abstract
| Authors: | Shah, G.; Lin, A.; Grumley, A.; Kamrowski, A.; Schofield, R.; Devlin, S.; Bhatt, V.; Proli, A.; Chung, D.; Dahi, P.; Lahoud, O.; Scordo, M.; Carlow, D.; Giralt, S.; Landau, H. |
| Abstract Title: | Successful pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT) |
| Meeting Title: | 17th International Myeloma Workshop |
| Keywords: | melphalan; pharmacokinetics; symptom burden |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 19 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2019 Sep 12-15 |
| Meeting Location: | Boston, MA |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2019-10-01 |
| Start Page: | e299 |
| End Page: | e300 |
| Language: | English |
| ACCESSION: | WOS:000491229800489 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.clml.2019.09.492 |
| Notes: | Meeting Abstract: SP-166 -- Source: Wos |
